Trump win boosts drug stocks as prospect of price curbs recedes

A trader sits in front of the computer screens at his desk at the Frankfurt stock exchangePharmaceutical stocks leapt on Wednesday as Republican Donald Trump&;s U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded. News that a Californian proposal aimed at reining in rising prices for prescription drugs was headed for defeat in a state ballot also buoyed the mood. Trump&039;s victory over Hillary Clinton, whose drug pricing criticisms have weighed on shares for more than a year, is not without risk, however.

Go to Source

Trump win boosts drug stocks as prospect of price curbs recedes

A trader sits in front of the computer screens at his desk at the Frankfurt stock exchangePharmaceutical stocks leapt on Wednesday as Republican Donald Trump&;s U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded. News that a Californian proposal aimed at reining in rising prices for prescription drugs was headed for defeat in a state ballot also buoyed the mood. Trump&039;s victory over Hillary Clinton, whose drug pricing criticisms have weighed on shares for more than a year, is not without risk, however.

Go to Source

Trump win boosts drug stocks as prospect of price curbs recedes

A trader sits in front of the computer screens at his desk at the Frankfurt stock exchangePharmaceutical stocks leapt on Wednesday as Republican Donald Trump&;s U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded. News that a Californian proposal aimed at reining in rising prices for prescription drugs was headed for defeat in a state ballot also buoyed the mood. Trump&039;s victory over Hillary Clinton, whose drug pricing criticisms have weighed on shares for more than a year, is not without risk, however.

Go to Source

1 2 3 5,920